Impact of proactive therapeutic drug monitoring of infliximab during the induction phase in IBD patients. A Bayesian approach.
Lidia Serrano-DíazCarles Iniesta-NavalónRosa Gómez-EspínIsabel Nicolás-de PradoEnrique Bernal-MorellLorena Rentero-RedondoPublished in: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva (2022)
proactive therapeutic drug monitoring using Bayesian approach is associated with higher primary response rates and fewer short-term complications.